Breaking News Instant updates and real-time market news.

HLT

Hilton

$93.92

0.34 (0.36%)

, MAR

Marriott

$131.50

-0.18 (-0.14%)

10:21
09/11/19
09/11
10:21
09/11/19
10:21

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hilton (HLT) initiated with an Outperform at Bernstein while Marriott (MAR) initiated with a Market Perform. 2. Ceridian (CDAY) initiated with an Overweight at Cantor Fitzgerald. 3. PacifiCare (PHS) initiated with an Outperform at William Blair. 4. Ollie's Bargain Outlet (OLLI) initiated with a Buy at Craig-Hallum. 5. ADP (ADP) initiated with an Outperform at Cowen while Paychex (PAYX) initiated with a Market Perform. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

HLT

Hilton

$93.92

0.34 (0.36%)

MAR

Marriott

$131.50

-0.18 (-0.14%)

CDAY

Ceridian

$51.97

0.22 (0.43%)

PHS

PacifiCare

$0.00

(0.00%)

OLLI

Ollie's Bargain Outlet

$65.17

1.01 (1.57%)

PAYX

Paychex

$80.71

0.01 (0.01%)

ADP

ADP

$162.79

-1.56 (-0.95%)

  • 12

    Sep

  • 13

    Sep

  • 23

    Sep

  • 24

    Sep

  • 02

    Oct

HLT Hilton
$93.92

0.34 (0.36%)

09/10/19
BERN
09/10/19
INITIATION
Target $108
BERN
Outperform
Hilton initiated with an Outperform at Bernstein
Bernstein started Hilton Worldwide Holdings with an Outperform rating and $108 price target.
09/11/19
BERN
09/11/19
INITIATION
Target $108
BERN
Outperform
Bernstein bullish on Hilton, initiates with an Outperform
As previously reported, Bernstein analyst Richard Clarke started coverage of Hilton with an Outperform rating and $108 price target. The analyst believes asset-light hotel model is a "fantastic business model," enabling fast growth, high returns and high cash generation. A recent valuation pullback and "misdiagnosed" cyclical fears provide a rare attractive entry point, he contends.
09/03/19
09/03/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boston Beer (SAM) downgraded to Underperform from Hold at Jefferies with analyst Kevin Grundy saying his consumer survey and web scrapes point to the potential for greater competitive intensity in the "rapidly growing" spiked seltzer category. He views Boston Beer's valuation as "stretched" given its competitive risk in hard seltzers. 2. Spirit Airlines (SAVE) downgraded to Outperform from Strong Buy at Raymond James with analyst Savanthi Syth now expecting a delay in the inflection of sentiment to early 2020. 3. AstraZeneca (AZN) downgraded to Sell from Hold at DZ Bank. 4. Heico (HEI) downgraded to Sell from Neutral at UBS with analyst Louis Raffetto citing valuation. 5. Hilton (HLT) downgraded to Neutral from Outperform at Macquarie with analyst Chad Beynon saying he believes the stock's current valuation with near-peak EBITDA multiples prices in the positives while the company faces a lack of catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/03/19
MACQ
09/03/19
DOWNGRADE
Target $98
MACQ
Neutral
Macquarie downgrades Hilton to Neutral, sees positives as priced in
Macquarie analyst Chad Beynon downgraded Hilton to Neutral from Outperform and lowered his price target on the stock to $98 from $102, stating that he believes the stock's current valuation with near-peak EBITDA multiples prices in the positives while the company faces a lack of catalysts. He expects weakening domestic RevPAR growth in Hilton's core midscale to upscale segments as supply remains elevated as the company approaches a tenth year of RevPAR expansion, Beynon tells investors.
MAR Marriott
$131.50

-0.18 (-0.14%)

07/17/19
BOFA
07/17/19
DOWNGRADE
Target $29
BOFA
Neutral
Pebblebrook Hotel downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Shaun Kelley downgraded Pebblebrook Hotel (PEB) to Neutral from Buy and lowered his price target for the shares to $29 from $33. The analyst expects a more cautious tone from Lodging companies during the Q2 earnings reports, particularly on corporate demand. He thinks full year guidance cuts "are now on the table" and downgraded Pebblebrook to reflect greater uncertainty. He continues to favor asset-light C-corps like Hilton (HLT), Marriott (MAR) and Wyndham Hotels & Resorts (WH) over the "more cyclical" Lodging real estate investment trust.
09/11/19
BERN
09/11/19
INITIATION
Target $136
BERN
Outperform
Bernstein bullish on Marriott, initiates with an Outperform
As previously reported, Bernstein analyst Richard Clarke started coverage of Marriott with an Outperform rating and $136 price target. The analyst believes asset-light hotel model is a "fantastic business model," enabling fast growth, high returns and high cash generation. A recent valuation pullback and "misdiagnosed" cyclical fears provide a rare attractive entry point, he contends.
09/10/19
BERN
09/10/19
INITIATION
Target $136
BERN
Market Perform
Marriott initiated with a Market Perform at Bernstein
Bernstein started Marriott International with a Market Perform rating and $136 price target.
08/06/19
JEFF
08/06/19
NO CHANGE
Target $140
JEFF
Buy
Marriott results to pressure shares near-term, says Jefferies
Marriott International's recent results are likely to pressure shares in the near term, Jefferies analyst David Katz tells investors in a post-earnings research note titled "Harder Than It Seems." The analyst believes investors are likely to focus on the company's moderated unit growth projections, reduced earnings guidance, and softer capital return projections. The combination of these factors in the context of an anticipated softening macro will challenge incrementally higher valuations, says Katz, who keeps a Hold rating on Marriott with a $140 price target.
CDAY Ceridian
$51.97

0.22 (0.43%)

09/11/19
CANT
09/11/19
INITIATION
Target $65
CANT
Overweight
Cantor Fitzgerald stars Ceridian at Overweight, sees upside to esimates
Cantor Fitzgerald analyst Drew Kootman last night initiated coverage of Ceridian HCM Holding with an Overweight rating and $65 price target. The company and platform have a "number of unique and positive attributes," including its global capabilities and opportunity, "strong" ecosystem of products, and increasing functionality, including its continuous payroll calculation, Kootman tells investors in a research note. He believes these will drive increased market penetration, accelerating growth rates, long-term margin expansion, and upside to consensus estimates.
09/06/19
MZHO
09/06/19
NO CHANGE
Target $65
MZHO
Buy
Ceridian recent selloff brings buying opportunity, says Mizuho
The recent pullback in shares of Ceridian HCM Holding represents an attractive buying opportunity, Mizuho analyst Siti Panigrahi tells investors in a research note. Ceridian shares dropped 4% yesterday, mainly due to the reported 9M secondary share offering, but no new shares were issued, says the analyst. Panigrahi reiterates a Buy rating on the shares with a $65 price target.
09/10/19
CANT
09/10/19
INITIATION
Target $65
CANT
Overweight
Ceridian initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Drew Kootman started Ceridian with an Overweight rating and $65 price target.
08/22/19
08/22/19
INITIATION
Target $65

Buy
Ceridian initiated with a Buy at Mizuho
As previously reported, Mizuho analyst Siti Panigrahi initiated Ceridian with a Buy rating and a price target of $65 as part of his broader research note into the cloud HCM software sector. The analyst believes that the company's acquisition of Dayforce has resulted in a modern cloud HCM and payroll platform driven by a "continuous processing engine" that positions Ceridian to capitalize on its international growth and expansion opportunity. Panigrahi also notes that Ceridian operates in a large and growing total addressable market.
PHS PacifiCare
$0.00

(0.00%)

09/11/19
WBLR
09/11/19
INITIATION
WBLR
Outperform
PacifiCare initiated with an Outperform at William Blair
William Blair analyst Matthew Phipps started PhaseBio Pharmaceutical with an Outperform rating. The analyst believes PB2452, a novel reversal agent of the platelet aggregation inhibitor ticagrelor, has a favorable risk profile and strong commercial potential. Despite the advancements of modern anticoagulants, the ability to turn off the therapy in the case of uncontrolled bleeding or emergency surgery remains a serious unmet medical need, Phipps tells investors in a research note. Based on the potential of PB2452 alone, the analyst estimates a risk-adjusted valuation of $16 per share, including cash on hand.
OLLI Ollie's Bargain Outlet
$65.17

1.01 (1.57%)

09/11/19
CHLM
09/11/19
INITIATION
Target $94
CHLM
Buy
Ollie's Bargain Outlet initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Jeremy Hamblin started coverage of Ollie's Bargain Outlet with a Buy rating and a $94 price target. The analyst views Ollie's as one of the most attractive growth stories in retail, with the company set to triple its store base over the next decade.
08/29/19
WELS
08/29/19
NO CHANGE
Target $60
WELS
Market Perform
Ollie's Bargain Outlet price target lowered to $60 from $85 at Wells Fargo
Wells Fargo analyst Edward Kelly lowered his price target for Ollie's Bargain Outlet to $60 from $85 after the company reported a "surprisingly bad quarter," as a litany of internal and external issues resulted in a material earnings disappointment. The analyst reiterates a Market Perform rating on the shares.
08/29/19
JPMS
08/29/19
NO CHANGE
Target $76
JPMS
Overweight
Ollie's Bargain Outlet earnings pullback a buying opportunity, says JPMorgan
JPMorgan analyst Matthew Boss views the post-earnings pullback in shares of Ollie's Bargain Outlet as a long-term buying opportunity. While the Q2 print puts the company in the "penalty box," Ollie's should return to high-teens growth in the second half of 2019 and 2020, Boss tells investors in a research note. He lowered his price target for the shares to $76 from $100 and keeps an Overweight rating on the name.
08/29/19
LOOP
08/29/19
NO CHANGE
Target $75
LOOP
Buy
Ollie's Bargain Outlet price target lowered to $75 from $100 at Loop Capital
Loop Capital analyst Anthony Chukumba lowered his price target on Ollie's Bargain Outlet to $75 after its "disappointing" Q2 performance that included the first decline in comps in 21 quarters, margin degradation, and a "substantial" earnings guidance cut. The analyst adds that the management's inability to foresee the problems in Q2 suggests that "some changes" may be needed to right the ship. Chukumba is keeping his Buy rating on the stock however, noting that the 30% pre-market decline looks "overdone" since Ollie's Bargain Outlet's wounds are "self inflicted" and "fixable".
PAYX Paychex
$80.71

0.01 (0.01%)

06/26/19
BOFA
06/26/19
DOWNGRADE
BOFA
Underperform
Paychex downgraded to Underperform from Neutral at BofA/Merrill
06/26/19
06/26/19
DOWNGRADE
Target $82

Underperform
Paychex downgraded to Underperform on valuation at BofA/Merrill
As previously reported, BofA/Merrill analyst Jason Kupferberg downgraded Paychex to Underperform from Neutral, with an $82 price target, as he sees valuation ahead of fundamentals. The analyst notes that the shares have outperformed significantly year to date and trade at a premium to historical levels. Further, Kupferberg sees the company's Q4 results/2020 guidance as in-line to slightly below consensus expectations. The stock has benefited from investor rotation related to the falling 10-year Treasury yield, he contends, adding that on the basis of underlying fundamentals, shares are "overvalued."
09/11/19
COWN
09/11/19
INITIATION
Target $86
COWN
Market Perform
Paychex initiated with a Market Perform at Cowen
Cowen analyst Bryan Bergin initiated Paychex with a Market Perform rating and a price target of $86. The analyst is positive on the company's position as a top human capital management provider to small-medium businesses and its healthy visibility, free cash flows, and leading margins. Bergin cautions however that the SMB employment market is "already tight", with the lack of upside catalysts keeping him on the sidelines until a better entry point emerges.
08/15/19
MSCO
08/15/19
DOWNGRADE
Target $74
MSCO
Underweight
Paychex cut to Underweight at Morgan Stanley on SMID business weakening
Morgan Stanley analyst Steven Wald downgraded Paychex (PAYX) to Underweight from Equal Weight and lowered his price target for the shares to $74 from $77 as he assumed lead coverage of the stock and ADP (ADP). Small-to-mid-sized business employment is weakening and Paychex's revenue is 94% correlated to small business employment, explained Wald. Additionally, Paychex shares remain expensive compared to its Payments peers based on his EPS, revenue and margin estimates, the analyst said. Wald maintained an Equal Weight rating on ADP upon assuming coverage, setting a $174 price target on the stock, up from the firm's prior $150 target. At current levels, the market is sufficiently balancing ADP's relatively defensive market position from serving a wider array of clients than Paychex against the cyclical risks to growth if employment conditions broadly worsen, said Wald.
ADP ADP
$162.79

-1.56 (-0.95%)

09/11/19
BOFA
09/11/19
DOWNGRADE
Target $175
BOFA
Neutral
ADP downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Jason Kupferberg downgraded ADP to Neutral from Buy with an unchanged price target of $175. After outperforming the S&P 500 Index by 35% over the past 18 months, driven by strong execution against margin expansion targets, the positive fundamental aspects of the story largely priced in, Kupferberg tells investors in a research note. Further, the analyst does not expect as much expansion in fiscal 2020 and 2021 compared to fiscal 2019.
09/11/19
COWN
09/11/19
INITIATION
Target $195
COWN
Outperform
ADP initiated with an Outperform at Cowen
Cowen analyst Bryan Bergin initiated ADP with Target $195, saying the "scale & sustainability" of its transformation are not fully valued. The analyst cites the "secular" growth in the human capital management industry, along with the company's continued margin expansion and material flexibility creating "multiple paths" for stock price upside. Bergin adds that ADP's product advancements should allow the company to "re-establish" its technology leadership.
07/31/19
JEFF
07/31/19
NO CHANGE
Target $176
JEFF
Hold
ADP price target raised to $176 from $167 at Jefferies
Jefferies analyst Samad Samana raised his price target on ADP to $176, saying its Q3 revenues came in line with expectations but margins beat consensus. The analyst adds that the top line benefited from sales related to the acquisition of a client list by the company and bookings were also strong. Samana keeps his Hold rating on ADP.

TODAY'S FREE FLY STORIES

MED

Medifast

$108.05

1.52 (1.43%)

09:28
09/23/19
09/23
09:28
09/23/19
09:28
Recommendations
Medifast analyst commentary  »

Medifast CFO confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FELE

Franklin Electric

$46.86

-0.66 (-1.39%)

, WTS

Watts Water

$95.13

-0.94 (-0.98%)

09:28
09/23/19
09/23
09:28
09/23/19
09:28
Conference/Events
Seaport Global to hold booth tours at conference »

Seaport Global Company…

FELE

Franklin Electric

$46.86

-0.66 (-1.39%)

WTS

Watts Water

$95.13

-0.94 (-0.98%)

XYL

Xylem

$77.61

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 31

    Oct

  • 18

    Nov

FSLR

First Solar

$66.69

-0.4 (-0.60%)

09:27
09/23/19
09/23
09:27
09/23/19
09:27
Hot Stocks
First Solar announces 25GW DC of photovoltaic modules shipped »

First Solar is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:27
09/23/19
09/23
09:27
09/23/19
09:27
Conference/Events
Water Environment Federation to hold a conference »

WEFTEC 2019 will be held…

09:26
09/23/19
09/23
09:26
09/23/19
09:26
Conference/Events
Barclays to hold a forum »

Payments & FinTech…

ADBE

Adobe

$277.84

-3.37 (-1.20%)

, ADP

ADP

$159.15

-0.15 (-0.09%)

09:26
09/23/19
09/23
09:26
09/23/19
09:26
Conference/Events
PagerDuty to hold a summit »

PagerDuty Summit 2019…

ADBE

Adobe

$277.84

-3.37 (-1.20%)

ADP

ADP

$159.15

-0.15 (-0.09%)

AMZN

Amazon.com

$1,793.64

-28.57 (-1.57%)

GOOG

Alphabet

$1,229.57

-10.03 (-0.81%)

IBM

IBM

$141.82

-1.17 (-0.82%)

MSFT

Microsoft

$139.34

-1.74 (-1.23%)

TWLO

Twilio

$114.39

-0.74 (-0.64%)

UBER

Uber

$32.52

-1.31 (-3.87%)

WORK

Slack Technologies

$25.39

-0.375 (-1.46%)

ZEN

Zendesk

$77.73

0.275 (0.36%)

ZM

Zoom Video

$82.68

-1.91 (-2.26%)

PD

PagerDuty

$29.89

0.785 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 13

    Nov

FQVLF

First Quantum Minerals

$0.00

(0.00%)

09:25
09/23/19
09/23
09:25
09/23/19
09:25
Hot Stocks
First Quantum granted right to enter option agreement on Dragonslayer project »

Millrock Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVCY

Central Valley Community

$21.49

0.88 (4.27%)

09:24
09/23/19
09/23
09:24
09/23/19
09:24
Downgrade
Central Valley Community rating change  »

Central Valley Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVE

Five Below

$126.54

-1.89 (-1.47%)

09:23
09/23/19
09/23
09:23
09/23/19
09:23
Recommendations
Five Below analyst commentary  »

Five Below's Ten…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$154.15

0.73 (0.48%)

09:22
09/23/19
09/23
09:22
09/23/19
09:22
Hot Stocks
Hershey completes acquisition of ONE Brands for $397M »

The Hershey Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$124.35

-2.51 (-1.98%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Hot Stocks
HCA Healthcare CHRO John Steele to retire, Jennifer Berres to succeed »

HCA Healthcare announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

REGN

Regeneron

$295.79

9.51 (3.32%)

, SNY

Sanofi

$46.50

1.61 (3.59%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Upgrade
Regeneron, Sanofi, Roche rating change  »

Guggenheim upgrades…

REGN

Regeneron

$295.79

9.51 (3.32%)

SNY

Sanofi

$46.50

1.61 (3.59%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 04

    Nov

SVMK

SurveyMonkey

$18.14

-0.16 (-0.87%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Hot Stocks
SurveyMonkey achieves ISO recognition from the British Standards Institute »

SurveyMonkey announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$18.46

-0.29 (-1.55%)

09:18
09/23/19
09/23
09:18
09/23/19
09:18
Hot Stocks
HP Inc. partners with WWF on forest protection, restoration, management »

HP announced its next…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
09/23/19
09/23
09:18
09/23/19
09:18
Options
Overnight activity included 303 trades in SPX and 5 trades in VIX »

303 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSCO

Nesco Holdings

$6.75

-0.055 (-0.81%)

09:17
09/23/19
09/23
09:17
09/23/19
09:17
Hot Stocks
Nesco Holdings to acquire Truck Utilities for $42.2M »

Nesco Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNPQY

BNP Paribas

$0.00

(0.00%)

09:16
09/23/19
09/23
09:16
09/23/19
09:16
Hot Stocks
BNP Paribas becomes founding signatory of Principles for Responsible Banking »

BNP Paribas became one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$46.50

1.61 (3.59%)

, REGN

Regeneron

$295.79

9.51 (3.32%)

09:16
09/23/19
09/23
09:16
09/23/19
09:16
Upgrade
Sanofi, Regeneron rating change  »

Sanofi upgraded to Buy on…

SNY

Sanofi

$46.50

1.61 (3.59%)

REGN

Regeneron

$295.79

9.51 (3.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

HZN

Horizon Global

$3.89

-0.12 (-2.99%)

09:15
09/23/19
09/23
09:15
09/23/19
09:15
Hot Stocks
Horizon Global appoints Terrence Gohl as CEOHorizon Global »

Horizon Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TA

TravelCenters

$12.46

-0.72 (-5.46%)

09:15
09/23/19
09/23
09:15
09/23/19
09:15
Hot Stocks
TravelCenters signs franchise agreement with Biggs Petroleum »

TravelCenters has signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABEO

Abeona Therapeutics

$3.26

-0.005 (-0.15%)

09:15
09/23/19
09/23
09:15
09/23/19
09:15
Hot Stocks
Breaking Hot Stocks news story on Abeona Therapeutics »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

PUYI

Puyi

$6.72

0.12 (1.82%)

09:14
09/23/19
09/23
09:14
09/23/19
09:14
Hot Stocks
Puyi appoints Yong Ren as CEO »

Puyi announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$50.91

-0.53 (-1.03%)

09:13
09/23/19
09/23
09:13
09/23/19
09:13
Hot Stocks
Textron says Cessna Citation Longitude receives FAA Type Certification »

Textron Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ACAD

Acadia

$40.81

-0.89 (-2.13%)

09:13
09/23/19
09/23
09:13
09/23/19
09:13
Hot Stocks
Acadia announces results from Phase 2 pimavanserin study »

Acadia announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MATN

Mateon Therapeutics

$0.00

(0.00%)

09:13
09/23/19
09/23
09:13
09/23/19
09:13
Hot Stocks
Mateon Therapeutics granted Rare Pediatric Disease Designation for OT101 »

Mateon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.